Tickers

1. Composite Trajectory Verdict

For a wholesale specialty insurance broker like RYAN, all three statements carry roughly equal weight: the income statement shows whether core broking and underwriting margins are holding up, the cash flow statement reveals the cash conversion of those margins after heavy acquisition spending, and the balance sheet tracks the leverage and goodwill burden from the roll-up strategy.

Composite Trajectory: Mixed

Revenue and operating income are growing at double-digit rates (total revenue +21.3% YoY to $3.05B; operating income +15.4% YoY to $493.6M), and operating cash flow rose 25% YoY to $643.7M (10-K 2025, Consolidated Statements of Operations; 10-K 2025, Consolidated Statements of Cash Flows). However, GAAP net income fell 6.9% YoY to $214.2M and diluted EPS dropped 34% to $0.47, driven by a 40% jump in interest expense to $222.4M and a $39.1M one-time tax charge from the Velocity acquisition CCR (10-K 2025, Consolidated Statements of Operations). The G&A expense ratio worsened to 14.9% from 14.0%, cash on hand declined 71% to $158.3M, and goodwill swelled 22% to $3.23B (10-K 2025, Consolidated Balance Sheets). Adjusted (non-GAAP) margins were stable but slightly lower (Adjusted EBITDAC margin 31.7% vs 32.2%; Adjusted net income margin 18.0% vs 19.6%) (10-K 2025, MD&A).

2. Red Flags

• GAAP net income margin compressed from 9.4% (2023) to 9.1% (2024) to 7.0% (2025) despite 21%+ revenue growth each year (10-K 2025, Consolidated Statements of Operations).
• Interest expense, net surged 40.4% YoY to $222.4M (2025) from $158.4M (2024), outpacing operating income growth (10-K 2025, Consolidated Statements of Operations).
• Amortization expense jumped 73.9% YoY to $274.4M, reflecting $140.8M of incremental customer-relationship intangibles from 2025 acquisitions (10-K 2025, MD&A; 10-K 2025, Note 6).
• Cash and cash equivalents fell 70.7% YoY to $158.3M while acquisition spending continued ($746.5M in 2025) (10-K 2025, Consolidated Statements of Cash Flows; 10-K 2025, Consolidated Balance Sheets).
• Tax Receivable Agreement liability grew to $459.0M (2025) from $436.3M (2024); estimated future tax savings of $540M assume sufficient future taxable income (10-K 2025, MD&A; 10-K 2025, Note 17).
• Contingent consideration liabilities at $148.4M fair value have a maximum potential payout of $597.4M (10-K 2025, Note 4).
• Goodwill represents 30.5% of total assets ($3.23B of $10.56B) after $537.6M of 2025 acquisition goodwill (10-K 2025, Consolidated Balance Sheets; 10-K 2025, Note 6).
• Deferred tax assets declined 30.8% to $310.1M from $448.3M, largely due to the Velocity CCR charge (10-K 2025, Consolidated Balance Sheets; 10-K 2025, MD&A).
• Non-GAAP Adjusted net income margin slipped from 19.6% to 18.0% YoY (10-K 2025, MD&A).
• Diluted EPS fell from $0.71 to $0.47 YoY (10-K 2025, Consolidated Statements of Operations).

3. Earnings Assessment (Income Statement)

Earnings Trajectory: Mixed

Total revenue grew 21.3% YoY to $3.05B, with organic revenue growth of 10.1% (vs 12.8% prior year) and acquisition contributions of 9.8% (10-K 2025, MD&A). Operating income rose 15.4% to $493.6M, but the operating margin dipped to 16.2% from 17.0% due to G&A ratio expanding to 14.9% from 14.0% (10-K 2025, Consolidated Statements of Operations). Net income declined 6.9% to $214.2M as interest expense jumped 40% to $222.4M and income tax expense nearly doubled to $79.0M (including a $39.1M CCR charge) (10-K 2025, Consolidated Statements of Operations; 10-K 2025, MD&A). Net income attributable to Ryan Specialty Holdings fell 33% to $63.4M, and diluted EPS dropped 34% to $0.47 (10-K 2025, Consolidated Statements of Operations). Compensation ratio improved to 59.1% from 63.2%, offset by higher amortization (10-K 2025, MD&A).

4. Cash Generation Assessment (Statement of Cash Flows)

Cash Trajectory: Mixed

Operating cash flow increased 25% YoY to $643.7M, driven by higher amortization ($274.4M), deferred tax expense from CCR ($48.6M), and working capital changes (10-K 2025, Consolidated Statements of Cash Flows). Capital expenditures rose to $68.0M from $47.0M, yielding free cash flow of approximately $575.7M (10-K 2025, Consolidated Statements of Cash Flows). Investing outflows of $834.0M were dominated by acquisitions ($746.5M net of cash acquired) and a $16.6M equity investment in VSIC (10-K 2025, Consolidated Statements of Cash Flows). Financing inflows of $78.1M reflected $1.33B of revolver borrowings offset by $1.26B of revolver repayments, $25.2M TRA payments, $62.3M dividends, and $29.3M contingent consideration payments (10-K 2025, Consolidated Statements of Cash Flows). Total cash (including fiduciary) fell to $1.58B from $1.68B; corporate cash alone dropped to $158.3M from $540.2M (10-K 2025, Consolidated Statements of Cash Flows).

5. Balance Sheet Assessment

Balance Sheet Trajectory: Mixed

Total assets grew 9.5% to $10.56B, led by goodwill (+21.8% to $3.23B), customer relationships (+7.5% to $1.50B), and fiduciary cash/receivables (+15.0% to $4.30B) (10-K 2025, Consolidated Balance Sheets; 10-K 2025, Note 6). Total liabilities rose 8.9% to $9.31B, with long-term debt up 1.9% to $3.29B and TRA liabilities up 5.2% to $459.0M (10-K 2025, Consolidated Balance Sheets; 10-K 2025, Note 8). Stockholders' equity increased 14.2% to $1.25B, but non-controlling interests represent 48.3% of total equity ($606.0M) (10-K 2025, Consolidated Balance Sheets; 10-K 2025, Note 9). Corporate cash declined 70.7% to $158.3M while revolver availability remains high ($1.33B undrawn of $1.40B capacity) (10-K 2025, Consolidated Balance Sheets; 10-K 2025, Note 8). Term loan principal amortization is modest ($54.8M due in 2026) with bulk maturity in 2031 (10-K 2025, Note 8).

6. Data Gaps

• Quarterly trends for 2026 (Q1, Q2) and 2025 (Q1-Q3) from the four 10-Q filings listed in the prompt header but not provided in the document text.
• Standalone quarterly revenue, operating income, and cash flow for 2025 and 2026 to assess intra-year seasonality and the impact of the Empower Program announced for Q1 2026.
• Segment-level operating profit or margin by Specialty (Wholesale Brokerage, Binding Authority, Underwriting Management) – only revenue by specialty is disclosed.
• Detailed breakdown of the $78.6M professional services/IT increase in G&A to assess sustainability.
• Projected Empower Program charges ($160M through 2028) and savings ($80M annualized from 2029) – only disclosed in MD&A, not yet reflected in financial statements.
• Sensitivity of contingent consideration fair value ($148.4M) to changes in acquired business performance – maximum payout $597.4M noted but scenario analysis not provided.
• Detailed maturity profile of Senior Secured Notes beyond the summary in Note 8 (only aggregate "Thereafter" bucket of $3.20B shown).